Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1999-11-22
pubmed:abstractText
The nematode Caenorhabditis elegans is the first animal whose genome is completely sequenced, providing a rich source of gene information relevant to metazoan biology and human disease. This abundant sequence information permits a broad-based gene inactivation approach in C. elegans, in which chemically mutagenized nematode populations are screened by PCR for deletion mutations in a specific targeted gene. By handling mutagenized worm growth, genomic DNA templates, PCR screens, and mutant recovery all in 96-well microtiter plates, we have scaled up this approach to isolate deletion mutations in >100 genes to date. Four chemical mutagens, including ethyl methane sulfonate, ethlynitrosourea, diepoxyoctane, and ultraviolet-activated trimethylpsoralen, induced detectable deletions at comparable frequencies. The deletions averaged approximately 1400 bp in size when using a approximately 3 kb screening window. The vast majority of detected deletions removed portions of one or more exons, likely resulting in loss of gene function. This approach requires only the knowledge of a target gene sequence and a suitable mutagen, and thus provides a scalable systematic approach to gene inactivation for any organism that can be handled in high density arrays.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-10022975, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-10051671, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-10066248, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-10068647, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-10077613, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-10192394, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-2231712, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-3221864, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-3744028, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-6589606, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-7906415, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-8395047, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-8628394, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-8752207, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-9159160, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-9229119, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-9288111, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-9335597, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-9342387, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-9381168, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-9417907, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-9486653, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-9588813, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-9647634, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-9712706, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-9851916, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-9851921, http://linkedlifedata.com/resource/pubmed/commentcorrection/10508845-9857046
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1088-9051
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
859-67
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
High-throughput isolation of Caenorhabditis elegans deletion mutants.
pubmed:affiliation
Axys Pharmaceuticals, NemaPharm Group, South San Francisco, California 94080, USA. lliu@cambriabio.com
pubmed:publicationType
Journal Article